products provider-evidence 
Bill of Health
MARCH 31, 2023
By Matthew Chun In a recent paper in Science Advances , researchers have proposed using neuroscientific data from brain scans to “improv[e] the state of evidence-based legal decision-making” in trademark infringement cases. But can — and more importantly, should — such evidence be used? A Role for Neuroscientific Evidence?
HIT Consultant
MAY 6, 2024
What You Should Know: – OM1 introduces three new products: OM1 Orion, OM1 Lyra, and OM1 Polaris powered by PhenOMTM – an artificial intelligence-powered digital phenotyping platform for personalized medicine and clinical research. Here’s how PhenOM tackles key pain points across the healthcare ecosystem: 1.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bill of Health
JUNE 29, 2023
ambulance) administration of blood products to patients with acute hemorrhagic shock. But there is a growing body of evidence spanning several decades that this is not beneficial and, in fact, can be harmful. There are several other requirements that make administration of blood products outside of the hospital setting difficult.
Healthcare It News
MARCH 4, 2024
WHY IT MATTERS Under terms that were not disclosed, WebMD said that it purchased Healthwise's operating assets, including content, products, technology, client relationships and certain trademarks, and will incorporate them into its Ignite platform.
Healthcare It News
NOVEMBER 14, 2022
The first phase of the partnership focuses on leveraging Wolters Kluwer’s healthcare information products – UpToDate, Lexicomp and Emmi, a personalized education tool – into new applications, like Digital Health Architect. WHY IT MATTERS. ON THE RECORD.
HIT Consultant
MAY 9, 2024
Tim Price, Chief Product Officer at Infermedica In an era where accessing health information is easier than ever, determining what is reliable poses increasing difficulty for health plan members. These tools tap validated sources to supply relevant, evidence-based information – a vital need when “Dr. Google” and “Dr.
Bill of Health
MARCH 13, 2023
This is because the regulatory landscape of health-related products contains loopholes that allow false or misleading claims to proliferate. Food and Drug Administration share jurisdiction over labelling, marketing, and advertising of dietary supplements, foods, drugs, devices, and other health-related products.
Expert insights. Personalized for you.
231 
Let's personalize your content